其他风险警示
Search documents
中科云网科技集团股份有限公司关于2025年年度报告编制及审计进展情况的公告
Shang Hai Zheng Quan Bao· 2026-02-27 21:14
Core Viewpoint - The company, Zhongke Yunwang Technology Group Co., Ltd., is currently facing significant financial challenges, including negative net profits and a warning of delisting risk due to its financial performance over the past three years [2][7]. Group 1: Financial Performance and Audit Progress - The company disclosed that for the fiscal year 2024, its total profit, net profit, and net profit after deducting non-recurring gains and losses were all negative, leading to a warning of delisting risk effective April 16, 2025 [2][3]. - The auditing firm, Lianda Certified Public Accountants, issued a qualified audit report for 2024, indicating substantial doubt about the company's ability to continue as a going concern [3][7]. - As of the date of the announcement, the audit for the 2025 fiscal year is ongoing, with the audit team conducting various procedures including confirmation letters, on-site inventory checks, and client interviews [4][6]. Group 2: Shareholder Meeting and Resolutions - The company held its first extraordinary general meeting of 2026 on February 27, 2026, with a total of 240 shareholders present, representing 22.37% of the voting shares [12][14]. - All proposed resolutions at the meeting were approved, including amendments to the company's articles of association and various governance rules, with significant support from both general and minority shareholders [16][18][20]. - Legal opinions were provided confirming that the meeting's procedures complied with relevant laws and regulations, ensuring the validity of the resolutions passed [36].
华西能源工业股份有限公司关于公司股票交易可能被实施退市风险警示的第二次提示公告
Shang Hai Zheng Quan Bao· 2026-02-27 20:27
Core Viewpoint - The company, Huaxi Energy Industrial Co., Ltd., is at risk of being delisted due to an expected negative net asset value of -40 million yuan at the end of 2025, which may lead to a *ST designation on its stock [2][3]. Group 1: Risk of Delisting - The company has issued a second warning regarding the potential delisting risk, as the preliminary financial assessment indicates a negative net asset value for 2025 [2][3]. - According to the Shenzhen Stock Exchange listing rules, if the audited net assets are negative, the company will receive a delisting risk warning after the annual report is disclosed [3][4]. - The company is required to issue at least two risk warning announcements before the annual report is disclosed, with this being the second such announcement [4]. Group 2: Internal Control Audit - The company received an audit report for the 2024 financial year indicating an inability to express an opinion on internal controls, leading to an "other risk warning (ST)" designation effective April 30, 2025 [5][7]. - The internal control audit for 2025 is ongoing, and the final audit opinion remains uncertain; if it is unfavorable, the company will face a delisting risk warning [6][7]. - The company has established a rectification leadership group to address the issues identified in the internal control audit and has begun implementing corrective measures [9][10]. Group 3: Progress on Rectification - The company has made progress in rectifying internal control deficiencies, including the completion of funding management and accounts receivable controls [11][12]. - Specific projects, such as the firefighting renovation and equipment installation for the Fuping EPC project, are still in progress, with plans for equipment acceptance and installation pending [11][15]. - The company has taken steps to ensure effective internal control operations and plans to apply for the removal of the risk warning once the necessary audit reports are obtained [15].
ST华西:公司股票被实施其他风险警示,整改工作正在进行
Xin Lang Cai Jing· 2026-02-27 09:45
Core Viewpoint - ST Huaxi announced that its 2024 annual financial report received an audit report with a disclaimer of opinion on internal controls, leading to the implementation of "other risk warning (ST)" on its stock starting from April 30, 2025 [1] Group 1 - The company has taken multiple corrective measures, including the establishment of a rectification leadership group and the formulation of an implementation plan [1] - As of now, several internal control rectifications, such as fund management and accounts receivable, have been completed, but the rectification of the Fuping EPC project remains unfinished [1] - The internal control audit for 2025 is currently underway, and if it receives a disclaimer or adverse opinion, the stock will face delisting risk warning (*ST) [1]
*ST东易:连续三日股价涨幅偏离值超12%,提示多项风险
Xin Lang Cai Jing· 2026-02-23 07:42
Core Viewpoint - The company *ST Dongyi announced that its stock experienced an abnormal fluctuation with a cumulative closing price deviation exceeding 12% over three consecutive trading days from February 11 to 13, 2026, but no significant undisclosed information was found [1] Group 1: Stock Performance and Risk Warnings - The company conducted a self-examination and found no major undisclosed information or significant media reports affecting the stock [1] - The company is under delisting risk warning due to negative net assets for 2024 and has been subjected to additional risk warnings for three consecutive years of negative non-recurring net profit from 2022 to 2024 [1] - If the company meets certain conditions in 2025, there is a risk of termination of its stock listing [1] Group 2: Additional Risks - The company highlighted risks related to business injections and donation projects [1]
浙江棒杰控股集团股份有限公司关于公司股票交易可能被实施退市风险警示及其他风险警示的提示性公告
Shang Hai Zheng Quan Bao· 2026-01-30 20:32
Core Viewpoint - Zhejiang Bangjie Holdings Group Co., Ltd. is at risk of being delisted due to negative net assets and negative net profits for the upcoming fiscal year, which may lead to the implementation of risk warnings on its stock trading [1][2][3]. Group 1: Financial Performance - The company estimates that by the end of 2025, the net assets attributable to shareholders will be between -900.1551 million and -600.1551 million (unaudited) [2]. - The projected net profit for 2025 is expected to be between -1.2 billion and -900 million, with the net profit after excluding non-recurring gains and losses estimated to be between -1.08 billion and -780 million [3][11]. - The company has reported negative net profits for the last three fiscal years, and the 2024 financial report included a significant uncertainty regarding its ability to continue as a going concern [3][11]. Group 2: Regulatory Compliance - According to the Shenzhen Stock Exchange's listing rules, if the company’s audited net assets are negative, it will face delisting risk warnings after the 2025 annual report is disclosed [1][4]. - The company is required to issue risk warning announcements if it anticipates conditions that may lead to delisting or other risk warnings, with specific timelines for disclosure [2][4]. Group 3: Operational Challenges - The company is facing significant operational challenges, primarily due to debt pressures from its photovoltaic subsidiary and production halts, leading to substantial fixed costs [11]. - The company is currently undergoing a pre-restructuring process, although it remains uncertain whether it will enter formal restructuring proceedings [5][15].
*ST中装(002822.SZ):撤销退市风险警示并继续实施其他风险警示暨临时停牌
Ge Long Hui A P P· 2026-01-20 13:03
Group 1 - The company *ST Zhongzhuang has completed its restructuring plan, and the Shenzhen Stock Exchange has approved the removal of the delisting risk warning due to the court's acceptance of the restructuring [1] - The company's stock will be suspended for one day starting January 21, 2026, and will resume trading on January 22, 2026, with the delisting risk warning lifted [1] - The stock's abbreviation will change from "*ST Zhongzhuang" to "ST Zhongzhuang," while the security code remains "002822," and the daily price fluctuation limit will continue to be 5% [1] Group 2 - In February 2024, the company's main bank accounts were frozen, triggering an "other risk warning" as per the Shenzhen Stock Exchange listing rules [2] - On March 21, 2025, the company received an administrative penalty notice indicating false financial disclosures for the years 2017-2021, leading to additional risk warnings [2] - As of the announcement date, the company continues to face multiple risk warnings due to unresolved issues from previous disclosures and audit reports indicating uncertainty in its ability to continue as a going concern [2]
贵州百灵:四年财务造假公司及相关负责人被罚2560万 董事长姜伟十年市场禁入
2 1 Shi Ji Jing Ji Bao Dao· 2025-12-22 04:14
Group 1 - The company Guizhou Bailing (002424.SZ) and 10 related individuals received an administrative penalty notice from the Guizhou Securities Regulatory Bureau for financial misconduct, including failing to adhere to the accrual basis of accounting [1][3] - From 2019 to 2021, the company understated sales expenses by 350 million, 241 million, and 64 million yuan respectively, leading to an overstatement of profits by up to 115.35% of the total reported profit for those periods; in 2023, sales expenses were overstated by 459 million yuan, with a profit understatement of 93.17% [1][3] - The company will be fined 10 million yuan and ordered to correct its financial statements; the former chairman Jiang Wei will face a 5 million yuan fine and a 10-year ban from the securities market [1][3] Group 2 - The company's stock will be suspended for one day on December 22, 2025, and will resume trading on December 23, 2025, with additional risk warnings; the stock name will change from "Guizhou Bailing" to "ST Bailing," while the stock code remains 002424, and the daily price fluctuation limit will be adjusted to 5% [2][3]
福能东方:因财务指标虚假记载,股票将被实施其他风险警示
Xin Lang Cai Jing· 2025-12-19 11:52
Core Viewpoint - The company received an administrative penalty notice from the Guangdong Securities Regulatory Commission due to false financial disclosures in its annual report, leading to a risk warning on its stock [1] Group 1: Regulatory Actions - The company was notified on December 19, 2025, regarding the administrative penalty for false financial reporting [1] - The stock will be subject to other risk warnings, and the trading will be suspended for one day starting December 22, 2025 [1] - The stock will resume trading on December 23, 2025, under a new name "ST福能," while the stock code remains unchanged [1] Group 2: Financial Reporting - The company is required to restate its financial reports and will apply to revoke the risk warning once it meets the necessary conditions [1]
*ST宁科(600165.SH):中科新材能否实现可持续正常生产经营能力仍不确定
智通财经网· 2025-12-18 14:36
Group 1 - The company's stock experienced an abnormal fluctuation, with a cumulative closing price increase of over 12% over three consecutive trading days on December 16, 17, and 18, 2025 [1] - The stock has been under other risk warnings by the Shanghai Stock Exchange since April 8, 2024 [1] - Although Zhongke New Materials has recently resumed production, there remains uncertainty regarding its ability to achieve sustainable normal production and operational capacity [1]
600608、600079,突发
Zheng Quan Shi Bao· 2025-12-12 12:35
Group 1 - *ST Hu Ke announced on December 12, 2025, that it received a notice of investigation from the China Securities Regulatory Commission (CSRC) due to suspected violations of information disclosure laws [1][3] - The company stated that its production and operational activities are currently normal and that the investigation will not have a significant impact on its management [3] - The main business of *ST Hu Ke focuses on the trade of agricultural and chemical products, classified under "F51 Wholesale Industry" according to the CSRC [3] Group 2 - For the third quarter, *ST Hu Ke reported a revenue of 1.04 million yuan, a year-on-year decrease of 56.95%, with a net profit attributable to shareholders of 1.0271 million yuan [4] - As of December 12, 2025, *ST Hu Ke's stock price was 3.81 yuan per share, with a total market capitalization of 1.253 billion yuan [4] Group 3 - On the same day, Renfu Pharmaceutical announced it received a notice of administrative penalty from the CSRC for failing to disclose non-operating fund occupation and significant omissions in its annual reports for 2020 and 2022 [7] - Renfu Pharmaceutical's stock will be subject to risk warnings starting December 16, 2025, with a trading limit of 5% on price fluctuations [7][9] - The company, established in 1993, is a leading pharmaceutical enterprise in Hubei Province, focusing on a full industrial chain from intermediates to drug formulations [9] Group 4 - As of December 12, 2025, Renfu Pharmaceutical's stock price was 18.15 yuan per share, with a total market capitalization of 29.625 billion yuan [9]